Julian Guillaumin, DVM, DACVECC, DECVECC joins us in this episode to discuss his JFMS Clinical Spotlight article, “Feline Aortic Thromboembolism: Recent advances and future prospects.” Dr. Guillaumin shares what sparked his interest in researching feline aortic thromboembolism (FATE), and details how the research and treatment options have changed over the past decade. Additionally, the discussion notes new treatment approaches for general practitioners in managing FATE in patients, why aspirin is no longer recommended, and what therapeutics to use instead. Other topics that are explored include the challenges in managing long-term pain in survival patients, the research finding that surprised Dr. Guillaumin, and the advances he hopes to see in protocols developed to mitigate repercussion injuries of FATE patients.
Read the article and access the supplemental material referenced in the episode:
Katie Tolbert, DVM, Ph.D., DACVIM-SAIM, SA Nutrition joins us on this episode to discuss her recent JFMS article, “Rational use of gastroprotectants in cats:...
In this episode of "All Cats Considered," Michelle Meyer, DVM, a general practitioner and past president of the FelineVMA, joins Luca Ferasin, DVM, PhD,...
In this month’s JFMS Clinical Spotlight, Christopher Scudder, BVSc, MVetMed, PhD, DACVIM-SAIM, DECVIM-CA, MRCVS sits down with Nathalie Dowgray, Head of ISFM, and delves...